Nomenclature for immune correlates of protection after vaccination.
about
Prime-boost immunization strategies against Chikungunya virusMeningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other PurposesVaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.New concepts in HIV-1 vaccine developmentWaning and aging of cellular immunity to Bordetella pertussisRecent developments in clinical trial designs for HIV vaccine researchImpact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backboneDengue: knowledge gaps, unmet needs, and research prioritiesSurvivors Remorse: antibody-mediated protection against HIV-1.Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Influenza immunology evaluation and correlates of protection: a focus on vaccines.Modeling HIV vaccine trials of the future.Analysis of two-phase sampling data with semiparametric additive hazards models.The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled TrialHIV-1 vaccines: challenges and new perspectivesNovel directions in HIV-1 vaccines revealed from clinical trialsApproaches to modelling the human immune response in transition of candidates from research to development.Model-robust inference for continuous threshold regression models.Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates.Immune correlates for dengue vaccine developmentVaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesFCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.History of vaccinationIncreased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2Dengue vaccines: recent developments, ongoing challenges and current candidates.Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doubApplying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamicsCalibration weighted estimation of semiparametric transformation models for two-phase sampling.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.Some extensions in continuous models for immunological correlates of protection.Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.Against vaccine assay secrecy.New prospects for a preventive HIV-1 vaccine.Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive IndividualsBreakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.
P2860
Q24701774-1E1944F3-CBDC-467C-969B-0FFB40BFAA71Q26782318-3502CE38-7924-47D5-AAAC-05EA9EF96BC6Q27675879-4C71D9D4-6DE3-4596-9264-DB7D46051250Q27687375-D6C163FD-FCEE-487A-AE59-1117E2D0D272Q28067027-948C4364-D6CE-4371-8815-0179269E96CAQ28080731-0169D8EE-1393-4F72-B844-F17D3D45B32CQ28083514-CE713E82-1ED6-4683-821B-5F5D51D705F1Q28535477-5F3316B4-3379-4A8E-9FB9-B0F860E8EE78Q28729764-4B416F62-47B2-470B-85D7-A6AC146D4ED2Q30238730-1B0C7402-3CA4-4FE7-87B0-53752B80E9B4Q30248749-2BF852D2-9D68-4C7D-87E9-20EFE2234B37Q30385397-A242891D-587C-474C-A923-A6D5EC8A8423Q30393307-E092ADAA-5CF9-4916-9C79-A968149D7C08Q31060985-9157BFE7-12FF-4A75-8163-9BEB2F0FC5D3Q33553771-77DCEF55-D8D4-4179-99F5-5AF0334AEDF9Q33577972-B0D9BD73-7AB5-4663-BAF3-6F29CA7418DDQ33645528-7DC36891-6815-4625-A6C0-88609B9CAFB3Q33661296-D383E6C2-B371-4B27-A526-0E4795A901C9Q33699928-25BFB2C2-D26C-4131-9027-C66DA82D9BA2Q33742529-1ADF1347-EC95-4213-98E8-E6535E976569Q33924674-E47B5C4F-B618-4226-A6A8-75ED4B560FD7Q33977866-CF5B26DF-E3B5-44B2-B1EB-4BD7AA42500CQ34057711-F7D84659-59BF-48F8-B8AE-11D2560CEBFBQ34117524-FEE2F01A-54E8-4C29-AC18-CD513C46A032Q34119899-CDE18AC8-1375-4546-AF92-741E23BE5336Q34298408-2791BB74-286C-480C-AE6E-6216792FF47CQ34367194-D0440C21-742F-4816-8666-2CED5176ED52Q34430200-FB9669A2-C125-4CB2-9955-D6B262AE30EFQ34500955-E970FED9-3971-423F-8DB3-620C08C8068DQ34669980-A8A70E67-9D5F-4BC2-9DF7-5FF86979C926Q35328844-8AE59234-8E84-42C1-8082-7B697DCD98ACQ35826733-7CF7BB49-3AB5-4AF9-84DE-886C675F60D7Q35845726-B49CB8FC-255F-48E4-BF7C-7FDE4D976A2FQ35878996-07E546E3-FDA9-421E-B57C-8FCAD6BEF26DQ35886464-D442BB93-73D1-42D1-88D7-0BBF38702F3BQ35887486-3B4DD23C-FBDB-433D-93E6-4FD908120166Q36223864-F3000ED6-A155-46B7-85C0-222DACE4228FQ36288468-4ABB84E9-5084-4B8D-AC5A-23A78BFBC590Q36334371-2EA496FE-B5AD-481B-B846-E05C7F17EE3FQ36335509-783717A2-E845-4693-BAC5-BBCC0B16455F
P2860
Nomenclature for immune correlates of protection after vaccination.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nomenclature for immune correlates of protection after vaccination.
@ast
Nomenclature for immune correlates of protection after vaccination.
@en
type
label
Nomenclature for immune correlates of protection after vaccination.
@ast
Nomenclature for immune correlates of protection after vaccination.
@en
prefLabel
Nomenclature for immune correlates of protection after vaccination.
@ast
Nomenclature for immune correlates of protection after vaccination.
@en
P2860
P356
P1476
Nomenclature for immune correlates of protection after vaccination.
@en
P2093
Peter B Gilbert
P2860
P304
P356
10.1093/CID/CIS238
P407
P577
2012-03-20T00:00:00Z